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ABSTRACT
Introduction: Despite the growing body of research
on quality and safety in healthcare, there is little
evidence of the association between the way hospitals
are organised for quality and patient factors, limiting
our understanding of how to effect large-scale change.
The ‘Deepening our Understanding of Quality in
Australia’ (DUQuA) study aims to measure and examine
relationships between (1) organisation and department-
level quality management systems (QMS), clinician
leadership and culture, and (2) clinical treatment
processes, clinical outcomes and patient-reported
perceptions of care within Australian hospitals.
Methods and analysis: The DUQuA project is a
national, multilevel, cross-sectional study with data
collection at organisation (hospital), department,
professional and patient levels. Sample size
calculations indicate a minimum of 43 hospitals are
required to adequately power the study. To allow for
rejection and attrition, 70 hospitals across all Australian
jurisdictions that meet the inclusion criteria will be
invited to participate. Participants will consist of
hospital quality management professionals; clinicians;
and patients with stroke, acute myocardial infarction
and hip fracture. Organisation and department-level
QMS, clinician leadership and culture, patient
perceptions of safety, clinical treatment processes, and
patient outcomes will be assessed using validated,
evidence-based or consensus-based measurement
tools. Data analysis will consist of simple correlations,
linear and logistic regression and multilevel modelling.
Multilevel modelling methods will enable identification
of the amount of variation in outcomes attributed to
the hospital and department levels, and the factors
contributing to this variation.
Ethics and dissemination: Ethical approval has
been obtained. Results will be disseminated to
individual hospitals in de-identified national and
international benchmarking reports with data-driven
recommendations. This ground-breaking national study
has the potential to influence decision-making on the
implementation of quality and safety systems and
processes in Australian and international hospitals.
INTRODUCTION
Despite decades-long efforts to improve
healthcare delivery systems worldwide, there
remain deﬁciencies in the quality and safety
of care patients receive.1–4 Hospitals are con-
tinuously assessed for levels of quality, safety
and performance using a range of methods,
bolstered by policies and regulatory activities
at national, state or regional, local, and hos-
pital levels.5 Assessments can be
resource-intensive, and are often conducted
with invalidated tools, or in a piecemeal
manner.6 Results are typically used to dem-
onstrate policy compliance, rather than to
stimulate improvement.
Strengths and limitations of this study
▪ This is an in-depth study examining quality man-
agement systems and patient factors in a large
sample of hospitals, substantially advancing
earlier work.
▪ We consulted widely with Australian and inter-
national stakeholders in order to operationalise
definitions and measures in acute myocardial
infarction, stroke and hip fracture.
▪ The study informs the design of future interven-
tions and quality management systems in
Australia and internationally.
▪ Key challenges include sufficient sample sizes,
the recruitment of hospitals (n=∼60), complex
ethical, governance and site approval processes
and attrition of recruited hospitals during the
approval process.
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Few studies in healthcare research systematically
examine relationships between quality interventions and
patient outcomes.7 Despite the growing body of
research, there is little evidence of the association
between the way hospitals are organised for quality and
patient outcomes, limiting our understanding of how to
effect large-scale change.8 9 In recognition of this, a
large multinational study ‘Deepening our
Understanding of Quality Improvement in Europe’
(DUQuE) was undertaken between 2009 and 2014.10
This landmark study, undertaken in 188 hospitals across
seven countries (Czech Republic, France, Germany,
Poland, Portugal, Spain and Turkey), examined the
effectiveness of quality management systems (QMS) and
strategies at organisation, department, professional and
patient levels for stroke, acute myocardial infarction
(AMI), hip fracture and obstetrics. DUQuE aimed to
improve the way quality strategies and their effects on
performance and outcomes were measured in European
hospitals11–14 by uncovering the relationships between
them. This study also aimed to identify factors inﬂuen-
cing the uptake of quality management activities by hos-
pitals, and establish the feasibility of using routinely
collected data to compare hospital performance.10
DUQuE developed and validated several tools for
European acute care hospitals, assessing the implemen-
tation of QMS,15 compliance with quality processes and
the extent of implementation of clinical quality strat-
egies at hospital level,16 departmental performance and
the implementation of quality management activities
across speciﬁc departments and care pathways,17 and
levels of clinical management provided by doctors and
nurses.18 Key published ﬁndings from DUQuE include:
▸ Low baseline performance and high variations were
found on a wide range of evidence-based quality and
safety indicators; levels of patient involvement in
quality management were found to be low and
appeared tokenistic;19 20
▸ Quality management was associated with clinical
effectiveness of care, and to a lesser extent for patient
safety culture; however, no link with patient-reported
experience of care was established;19 21
▸ Greater variation of evidence-based organisation and
patient safety strategies was found within, rather than
between, countries;22
▸ An organisational management structure which sup-
ports innovation in care was associated with a more
developed QMS;23
▸ Discussions of quality performance at executive
board-level meetings were associated with higher
levels of quality management;24 and
▸ Accreditation and certiﬁcation were associated with
clinical leadership, systems for patient safety and clin-
ical review, but not with clinical practice.25
DUQuE produced an evidence-based guide on
effective quality and safety strategies to assist purchas-
ing agencies and hospital managers with decisions on
implementation and improvement.26 However, despite
providing evidence of associations between hospital
quality and a range of processes and outcomes, gener-
alisability of DUQuE ﬁndings are limited to Europe.
Extending this work to other healthcare systems will
provide in-depth understanding of the relationships
that exist within these systems, and will enable
hospital benchmarking using standardised measures
both within and between countries—an international
ﬁrst.
While DUQuE took a pathway analysis approach, it did
not distinguish between QMS and clinical treatment pro-
cesses delivered in emergency departments (EDs) and
those of inpatient departments treating patients with
stroke, AMI and hip fracture. Given that the ED is a
common point of entry for all three conditions, inclu-
sion of ED factors in the data for each condition is likely
to bias the study towards ED performance. It is also
likely that differences will exist between the quality of
care delivered in the ED and other hospital departments
providing care for stroke, AMI and hip fracture following
admission, thereby biasing the ﬁndings for those depart-
ments.27 Although there is work distinguishing the
quality of care provided in the ED, and other inpatient
department care,28 the relationship between quality
strategies used in the ED, and quality of care provided
in the ED, has not been assessed. In addition, no distinc-
tion has been made between quality strategies and
quality of care provided in the ED and quality strategies
and quality of care provided in subsequent inpatient
departments for any acute medical condition.
Understanding the components of ED care in relation
to speciﬁc care pathways can help identify which aspects
of care are attributable to the ED versus other wards or
departments. It is important to monitor the critical ED
segment of care and distinguish this from care provided
elsewhere,28 so that barriers to the delivery of guideline-
concordant, evidence-based care can be identiﬁed and
addressed using relevant, context-speciﬁc interventions.29
The Deepening our Understanding of Quality in
Australia (DUQuA) study involves substantial modiﬁca-
tion to the DUQuE study design, to advance the inter-
national evidence base. DUQuA aims to measure and
examine relationships between organisation, depart-
ment, and patient level factors within Australian hospi-
tals. Speciﬁc research questions are:
1. What department-level factors (ie, QMS, leader-
ship, culture) are associated with patient-level
factors (ie, clinical treatment processes, patient
perceptions of care and nationally recorded clin-
ical outcomes)?
2. What organisation-level factors (ie, QMS, size, loca-
tion) including ED factors (ie, QMS, leadership,
culture) are associated with patient-level factors (ie,
clinical treatment processes, patient perceptions of
care and nationally recorded clinical outcomes)?
How much does each factor contribute to the total
variation in patient factors?
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METHODS AND ANALYSIS
Conceptual framework
Working with DUQuE research leads (RS and OG),
members of the DUQuA team (RC-W, NT and JB)
assessed the evidence from DUQuE to reﬁne the con-
ceptual model. The DUQuA team (RC-W, NT, VP, EH
and JB) developed the analytical framework iteratively at
strategic and methodological meetings, streamlined the
original model, and built the ﬁnal main constructs and
the relationships we aim to test.
In line with DUQuE, we aim to further our under-
standing of the characteristics of Australian hospitals
and hospital departments, and examine links to the
quality of care provided to patients.9 10 The DUQuA
conceptual model (ﬁgure 1) outlines the expected rela-
tionships between organisation (hospital) and
department-level constructs with patient-level factors (ie,
clinical treatment processes, patient perceptions of care
and nationally recorded outcomes) in three care path-
ways: stroke, AMI and hip fracture. Selection of these
conditions is addressed below.
The speciﬁc objectives of DUQuA are to assess rela-
tionships between: (1) department-level QMS, leader-
ship, culture and patient-level factors; (2)
organisation-level QMS and patient-level factors; and (3)
ED QMS, leadership, culture and patient-level factors.
Research design
The DUQuA project is a multilevel, cross-sectional
study with data collection at organisation, department,
professional and patient levels in hospitals across
Australia. Organisation-level measures will consist of
external assessment and self-reported QMS, and
department-level measures will consist of external
assessment of QMS and self-reported perceptions of
leadership and culture. Patient-level measurements
based on clinical treatment processes, patient percep-
tions of care and nationally recorded clinical outcomes
are nested in hospital departments, which are in turn
nested in hospitals in each of the six Australian states
and two territories.
Sample size
Given our research design requires multilevel analysis,
we used the following equation30 to determine the
design effect of the study and inﬂate the sample size
accordingly:
nh ¼
mp  [1þ (np;h  1) ICC]
np;h
where nh is the number of hospitals, mp the number of
departments needed in a one-level regression according
to a standard sample size calculation, np,h the number
of departments per hospital (in this case three), and
ICC the intraclass correlation coefﬁcient.
The sample size for the DUQuA multilevel model is
the design effect multiplied by the sample size required
for a standard linear regression. To identify which ICC to
use to calculate our sample size, we used an α of 0.05 and
power of 80%, in line with convention, and undertook a
literature search of similar studies and ICCs. Taljaard
et al31 published a set of ICCs for maternal health out-
comes from the 2005 WHO Global Survey on Maternal
and Perinatal Health. The ICC for the only continuous
process variable analysed was 0.081, the median ICC for
all process measures was 0.161, and the median for all
continuous measures was 0.05. The same study indicated
that ICCs for institutions tended to be larger for clinical
treatment processes than patient outcomes. Similarly, for
process variables in primary care settings, Campbell
et al32 found that the ICC tended to range between 0.05
and 0.15, compared with outcome variables which were
generally less than 0.05. James33 reported a median ICC
of 0.12 for measures of organisational climate, and
Forbes and Taunton34 reported a hospital-level ICC of
0.03–0.07 for three organisational phenomena. Smits
et al35 also published hospital-level ICC for patient safety
culture-related outcomes, all of which are under 0.07.
Taking this into account, an ICC of 0.16, higher than
most ICCs in the literature, was used to calculate a conser-
vative sample size. It reﬂects the median from the mater-
nal health process measures, the most similar group of
available reported ICCs. For this ICC, the minimum
sample size required to answer our primary research
question is 43 hospitals. However, in order to increase the
power of the study, to be in line with simulation papers
(which have shown that standard errors are estimated to
be inadequate by 15% with <50 clusters),36 and to allow
for hospital refusal to participate or subsequent with-
drawal, a decision to oversample at the organisation level
was made.
Selection of clinical conditions
DUQuE originally tested relationships between QMS
and four conditions (AMI, stroke, hip fracture and
Figure 1 DUQuA conceptual model (DUQuA, Deepening
our Understanding of Quality in Australia; QMS, quality
management systems).
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obstetrics). These conditions were selected because
they cover a broad range of hospital care, there are
evidence-based standards for clinical treatment pro-
cesses against which compliance could be assessed, and
there is demonstrated variability in both compliance
with clinical treatment process measures and nationally
reported outcomes of care, such as complications or
mortality, allowing for analysis of associations between
these measured constructs.10 DUQuE conditions were
retained except obstetrics; in Australia, maternity care
is often provided in dedicated hospitals. Replacement
conditions were considered but none were deemed
suitable due to a lack of evidence-based standards for
clinical treatment processes, or a lack of variability in
compliance with processes or outcomes.
Selection and recruitment of hospitals
Hospitals will be approached in all jurisdictions: the
Australian Capital Territory (ACT), New South Wales
(NSW), the Northern Territory (NT), Queensland
(QLD), South Australia (SA), Tasmania (TAS), Victoria
(VIC) and Western Australia (WA). To guarantee
adequate data for collection, the inclusion criteria are
(1) general public hospitals with approximately 200
beds or more, (2) with an ED, and (3) that regularly
admit more than 30 each of stroke, AMI and hip frac-
ture patients over a 3-month period. Preliminary work
indicated that 70 hospitals meet these criteria and will
be invited to participate. Table 1 lists the number of hos-
pitals identiﬁed as eligible to participate by state.
The Director of Medical Services (DMS), or an equiva-
lent senior hospital leader, will be the initial point of
approach for recruiting hospitals. Following discussion
with the DMS and other relevant hospital stakeholders,
a letter will be sent to the hospital executive team of eli-
gible hospitals inviting their participation. The DMS or
equivalent will be recruited as a ‘Local Principal
Investigator’ (LPI) at each hospital that accepts this invi-
tation, acting as a hospital coordinator. For each hos-
pital, one or more healthcare professionals will be
recruited to support the LPI and coordinate data collec-
tion. The Royal Australasian College of Medical
Administrators (RACMA) has agreed to support the
DUQuA team during recruitment and data collection.
Other recruitment methods, including engaging a hos-
pital executive network, or personal invitation, will be
employed as necessary. LPIs and healthcare profes-
sionals will assist in operationalising the standardised
recruitment strategy for staff and patients.
Selection and recruitment of participants
The source population for the study includes the Quality
Manager at each participating hospital; all clinicians treat-
ing patients with stroke, AMI and hip fracture; and all
patients with stroke, AMI and hip fracture meeting the
study inclusion criteria. Where possible, we have adopted
the same inclusion/exclusion criteria as DUQuE (The
DUQuE Project team. Deepening our Understanding of
Quality Improvement in Europe: Manual for Hospital
Coordinators [unpublished material], 2011.). Speciﬁc
details on selection of participants follows.
Quality Manager
Description
This is the person responsible for the coordination of
quality improvement activities in the hospital. He or she
should have a good overview of all activities supporting
quality improvement. This may be a formally appointed
Quality Manager, or another professional in charge of
managing aspects of quality in the hospital.
Recruitment
The Quality Manager will be invited by the DUQuA team
to complete the Quality Management Systems Index
(QMSI) questionnaire (see ‘Organisation-level mea-
sures’). If more than one professional meets the descrip-
tion, then the most experienced person will be invited to
participate until one questionnaire is completed.
Clinicians
Description
Clinicians will be invited to complete leadership and
culture questionnaires. Clinician inclusion criteria are
doctors, nurses and allied health professionals practising in
the clinical area of the ED or a particular pathway (stroke,
AMI, hip fracture) for at least 50% of their work time.
Recruitment
All clinicians that meet the inclusion criteria will be
invited to participate in the leadership and culture ques-
tionnaire (see ‘Department-level measures’) until a
minimum of 20 questionnaires for each department are
completed at each hospital. The DUQuA team will
invite clinicians to complete the questionnaire, by coord-
inating the dissemination of a web link to the online
questionnaire.
Patients
Description
There are two patient-level measures that involve the col-
lection of patient data. The inclusion criteria for each
condition are listed in table 2. Patients who are admitted
Table 1 Number of eligible hospitals by state or territory
State/territory
Number of eligible
hospitals
Australian Capital Territory 2
New South Wales 24
Northern Territory 1
Queensland 13
South Australia 4
Tasmania 2
Victoria 18
Western Australia 6
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to the hospital with a primary diagnosis other than
those listed in table 2 will be excluded.
Recruitment for patient perceptions of care measure
All patients meeting the inclusion criteria who present
to the hospital during the study period will be invited to
complete the questionnaire. Additional criteria and
screening will be applied to ensure that participation is
voluntary and that participants are able to give informed
consent. Healthcare professionals at each hospital will
be trained to invite patients to complete the question-
naire. Recruitment will continue until a minimum of 30
questionnaires are completed for each condition at each
hospital.
Clinical treatment processes indicator audit
The inclusion criteria (table 2) will be applied to
records of patients admitted to the hospital between
September 2014 and February 2015. Records of patients
admitted to the hospital with a primary diagnosis other
than those listed in table 2 will be excluded. For each
condition in each hospital, 60 consecutive patient
medical records will be extracted and reviewed until 30
audits of patients meeting the inclusion criteria have
been completed. Healthcare professionals trained by the
DUQuA team will undertake the medical record reviews.
Development, selection and collection of measures
Measures developed and validated for DUQuE9 10
15–17 22 37 were initially considered for DUQuA. During a
3-day consultation with the DUQuE lead researchers (RS
and OG), we agreed on which constructs should be
excluded from the DUQuA study based on a lack of rele-
vance to the Australian healthcare system, poor variance
demonstrated by a particular measure, an absence of a
relationship with any other variables measured in
DUQuE, or misalignment of the construct with our
revised theoretical framework. Excluded constructs are:
external pressure, hospital governance, hospital culture, hospital
professional involvement, patient involvement in quality man-
agement and professionalism.
To establish new constructs not assessed as part of
DUQuE (ie, department-level leadership and culture),
literature reviews were performed to identify existing
measures. Explicit criteria were used to assess and select
measures, including psychometric properties, level of
evidence and appropriateness for the Australian health-
care system. In particular, the signiﬁcance of interhospi-
tal transfers in the care of patients with stroke, AMI and
hip fracture was identiﬁed. Australian studies indicate
that 14% of patients with hip fracture and a quarter of
patients with AMI are transferred between hospitals, and
63% of Australian hospitals have ED protocols for inter-
hospital transfers of patients with stroke.38–40
Consequently, variables regarding the potential impact
of interhospital transfer were incorporated to allow for
their measurement.
Where the DUQuE measures or items were unsuitable
for the Australian context, or where it was felt that
newer evidence-based measures were available, we
reviewed the literature for new measures, consulted with
expert clinicians and reﬁned speciﬁc items to ensure
measures were appropriate and relevant. Stakeholder
groups of healthcare professionals and researchers with
expertise in clinical practice, quality or both were estab-
lished to inform revisions to DUQuA measures and the
introduction of new measures. New measures have been
piloted in at least one hospital ( June 2015 and
September 2015) to assess suitability and feasibility of
use. The ﬁnal list of DUQuA measures, content descrip-
tions, evidence of reliability and validity, and data collec-
tion methods, is provided in table 3.
Organisation-level measures
Development and selection
The three measures of organisation-level QMS are the
QMSI, the Quality Management Compliance Index
(QMCI) and the Clinical Quality Implementation Index
(CQII). These measures, validated by DUQuE, have
been modiﬁed by the DUQuA team in consultation with
national quality assessment experts (eg, the Australian
Council on Healthcare Standards) for the Australian
context and to reﬂect changes made to the condition-
Table 2 Patient inclusion criteria
Condition Inclusion criteria
Stroke Patients aged 18 years and older, with a principal diagnosis code of acute ischaemic stroke OR not specified
stroke. Include patients with a principal diagnosis code of: (1) ICD 10 I63 or (2) ICD 10 I64
AMI Patients aged 18 years and older, with a principal diagnosis code of AMI according to: (1) ICD 10 I21 or ICD
10 I22 and (2) ECG changes associated with STEMI: new LBBB or persistent ST-segment elevation ≥1 mm
in two or more contiguous ECG leads and (3) blood sampling shows elevated serum markers of myocardial
necrosis for creatine kinase MB form and troponins
Hip fracture Patients aged 65 years and older, with at least one of the primary diagnosis criteria of: (1) fractura colli
femoris (ICD 10 S72.0) or (2) fractura pertrochanterica (ICD 10 S72.1) or (3) fractura subtrochanterica
femoris (ICD 10 S72.2)
AMI, acute myocardial infarction; ICD, International Classification of Diseases; LBBB, left bundle branch block; MB, myocardial band;
STEMI, ST-segment elevation myocardial infarction.
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Table 3 DUQuA measures: content, evidence of reliability and validity, and collection methods
Measures Content Reliability and validity Collection methods
Organisation-level QMS
QMSI Ten subscales: quality policy; hospital
governance board activities; quality resources;
quality management; evidence-based
medicine protocols; preventive protocols;
internal quality methods (for general activities,
personnel, clinical practice, patients)
Satisfactory internal consistency (0.72–
0.82) was demonstrated for eight scales.
The scale with the low coefficient—
analysing feedback and patient
experiences (α=0.48)—was retained due to
the theoretical importance of this topic15*
Self-report questionnaire completed by the
hospital’s Quality Manager or equivalent
(n=1)
QMCI Four subscales: quality planning; monitoring
patient and professional opinions; quality
control and monitoring; improving quality of
care
Cronbach’s reliability coefficients were
satisfactory (0.74–0.78) for the four
scales16*
Quality assessment by experienced
hospital surveyor (site visit)
CQII Seven subscales: preventing and controlling
healthcare associated infections; medication
safety; preventing patient falls; preventing
pressure injuries; routine assessment and
diagnostic testing of patients in elective
surgery; safe surgery that includes an
approved checklist; recognising and
responding to clinical deterioration in acute
healthcare
Cronbach’s reliability coefficients were
satisfactory (0.82–0.93) for the seven
scales16*
Quality assessment by experienced
hospital surveyor (site visit)
Department-level QMS
SER Assignment of clinical responsibilities for a
condition
Factor loadings and Cronbach’s α values
reported as: AMI (0.58–0.63, α=0.69),
stroke (0.29–0.50, α=0.46), and hip fracture
(0.65–0.69, α=0.76)17*
Quality assessment by experienced
hospital surveyor (site visit)
EBOP Organisation of department processes
(admission, acute care, and discharge to
facilitate evidence-based care
recommendations)
It was not possible to build one generic
scale for the EBOP, because it consists of
different items across pathways17*
Quality assessment by experienced
hospital surveyor (site visit)
PSS Use of international consensus based patient
safety recommendations
Despite the same items being used across
pathways for PSS, factor analysis did not
produce a generic scale for the four
pathways17*
Quality assessment by experienced
hospital surveyor (site visit)
CR Integration of audit and systematic monitoring
in departmental quality management
mechanisms
Factor loadings and Cronbach’s α values
reported as: AMI (0.64–0.91, α=0.86),
stroke (0.65–0.93, α=0.84), and hip fracture
(0.36–0.91, α=0.76)17*
Quality assessment by experienced
hospital surveyor (site visit)
Department-level culture and leadership
SAQ and Shipton and
colleagues’ Leadership
Effectiveness Scale
Three subscales: teamwork climate (the
perceived quality of collaborating between
personnel); safety climate (perceptions of a
strong and proactive organisational
Composite scale reliability for the SAQ was
0.90 (Raykov’s ρ coefficient), indicating
strong reliability41
Validated in a survey of approximately
Combined into a self-report questionnaire
completed by doctors, nurses, and allied
health professionals working in stroke,
Continued
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Table 3 Continued
Measures Content Reliability and validity Collection methods
commitment to patient safety); perceptions of
management (administrative and managerial
support, staffing levels, and managerial style
in the workplace)
Leadership effectiveness (staff perceptions of
the effectiveness of healthcare leaders in their
workplace)
18 000 employees of the National Health
Service in the UK (Cronbach’s α=0.92)42
AMI, and hip fracture wards, and the ED
(n=80)
Patient-level clinical treatment processes
Clinical audit tools Nationally recognised process composite
indicators based on evidence of impact on
patient outcomes
NA Patient data retrieved from national
registries and/or by medical record review
(n=90)
Patient-level outcomes
Nationally collected audit
data
Includes readmission and mortality rates, and
length of stay
NA Collected from publicly available national
data
Patient perceptions of care
PMOS Eight domains: communication and team
work; organisation and care; access to
resources; ward type and layout; information;
staff roles and responsibilities; staff training;
equipment
Reliability was established using
Cronbach’s α (0.66–0.89) and test-retest
reliability (r=0.75). The positive index
significantly correlated with staff reported
‘perceptions of patient safety’ (r=0.79) and
‘patient safety grade’ (r=−0.81) outcomes
from the Agency for Healthcare Research
and Quality Safety Culture Survey,
demonstrating convergent validity43
Self-report or assisted questionnaire
completed by patients meeting the
inclusion criteria (AMI, stroke, and hip
fracture) (n=90)
n, participants per hospital.
*Reliability and validity details for original DUQuE measures, not the adapted versions.
AMI, acute myocardial infarction; CR, Clinical Review; CQII, Clinical Quality Implementation Index; DUQuE, Deepening our Understanding of Quality Improvement in Europe; EBOP,
Evidence-Based Organisation of Pathways; ED, emergency department; NA, not available; PMOS, Patient Measure of Safety; PSS, Patient Safety Strategies; QMS, quality management
systems; QMCI, Quality Management Compliance Index; QMSI, Quality Management Systems Index; SAQ, Safety Attitudes Questionnaire; SER, Specialized Expertise and Responsibility.
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speciﬁc indicators. The adapted QMSI is a seven-
subscale survey which provides a proxy measure for the
managerial aspects of quality management that might
inﬂuence the implementation of quality systems in hos-
pitals.15 The adapted QMCI is a four-subscale proxy
measure for compliance with procedures used to plan,
monitor and improve quality of care.16 The adapted
CQII is a seven-subscale proxy measuring implementa-
tion of QMS, including whether specialised quality man-
agement committees and hospital policies exist, and the
level of compliance monitoring, system sustainability and
improvement focus.16
Collection
The Quality Manager will complete the self-report paper
QMSI questionnaire. The QMCI and CQII will be com-
pleted in a quality assessment site visit by experienced
external hospital surveyors who will be trained by the
DUQuA team.
Department-level measures
Quality management systems
Development and selection
A modiﬁed version of a checklist developed and vali-
dated by DUQuE17 will assess department-level QMS.
The four measures (see table 3) are Specialized
Expertise and Responsibility (SER), Evidence-Based
Organisation of Pathways (EBOP), Patient Safety
Strategies (PSS) and Clinical Review (CR).17
Collection
Department-level QMS assessment will be completed in
a quality assessment site visit by experienced external
hospital assessors drawn from a pool of Australian
Council on Healthcare Standards surveyors who will be
trained by the DUQuA team.
Culture and leadership
Development and selection
The culture measure consists of two domain subscales
from the Australian version44 of the validated Safety
Attitudes Questionnaire (SAQ)41 ‘Teamwork climate’
and ‘Safety climate’. Two scales, each previously vali-
dated and measured on a four-point Likert scale, were
combined to form the leadership measure: the
‘Perceptions of management’ domain subscale from the
SAQ,41 and the Leadership Effectiveness Scale.42 These
measures are combined in one questionnaire.
Collection
Clinicians will complete the self-report questionnaire
online.
Patient-level measures
Clinical treatment processes indicators
Selection
The DUQuA team started with indicators for each condi-
tion used in the DUQuE study,10 and reﬁned these
following consultation with expert stakeholder groups
for each condition and the Australasian College for
Emergency Medicine (ACEM), and examination of indi-
cators used by condition-speciﬁc Australian national
registries. Box 1 presents the ﬁnal list of DUQuA clinical
treatment process indicators.
Development of stroke indicators
DUQuE clinical treatment process indicators for stroke
were presented to an expert stakeholder group that
included members of the National Stroke Foundation
(NSF). The NSF collects cross-sectional data in a bien-
nial review of 40 consecutive eligible patient medical
records by trained auditors of stroke clinical treatment
processes over a 6-month period, from approximately
177 hospitals across Australia. Indicators developed for
this registry align with the ‘Indicator Speciﬁcation:
Acute Stroke Clinical Care Standard’, developed by the
Australian Commission on Safety and Quality in Health
Care (ACSQHC) and certiﬁed by the Federal Minister
for Health.45 Therefore, the indicators were amended to
align with the NSF Clinical Audit and the national
ACSQHC standards.
Development of AMI indicators
DUQuE AMI clinical indicators were compared against
the ‘Indicator Speciﬁcation: Acute Coronary Syndromes
Clinical Care Standard’, developed by the ACSQHC and
certiﬁed by the Federal Minister for Health.46 Final indi-
cators chosen for DUQuA align with the relevant indica-
tors in this document.
Development of hip fracture indicators
DUQuE hip fracture clinical indicators were modiﬁed for
DUQuA in consultation with the Co-Chair of the Australian
and New Zealand Hip Fracture Registry (ANZHFR), and
the guidelines produced by the ANZHFR.47
Collection
An audit of clinical treatment process indicators will be
undertaken. For hospitals that submit data to the NSF
Clinical Audit, data will be directly retrieved from the
most recent audit (September 2014 to February 2015)
within the NSF database.i In hospitals not contributing
to the NSF Clinical Audit, data will be collected via
medical record review. As no national AMI or hip frac-
ture registries were active during the NSF data collection
period, AMI and hip fracture clinical treatment process
data will also be collected via medical record review.
iThe NSF provides training to internal clinicians for its biennial audit.
The NSF reviews 40 consecutive medical records for each hospital.
A random sample of 30 records will be selected for each participating
DUQuA hospital.
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Box 1 Deepening our Understanding of Quality in Australia (DUQuA) clinical treatment process indicators for stroke, acute
myocardial infarction (AMI) and hip fracture
▸ Clinical treatment process indicators (acute ischaemic stroke OR not specified stroke)
1. Patient screened for stroke according to validated stroke screening tool (eg, FAST or ROSIER scale)
2. Patient screened for eligibility* for thrombolysis (intravenous recombinant tissue plasminogen activator (Rt-PA))
3. Patient received a brain scan within 60 min of arrival to the hospital
4. Eligible* patient received intravenous rt-PA†
5. Eligible* patient received intravenous rt-PA† within 60 min of arrival to the hospital
6. Swallow screen or swallow assessment performed before the patient was given oral food or fluids, or oral medication
7. Patient admitted to stroke unit
8. Patient spent at least 90% of their acute hospital admission on a stroke unit
9. Patient discharged on statin therapy or lipid-lowering medication unless contraindicated‡
10. Patient without atrial fibrillation discharged on antiplatelet therapy unless contraindicated‡
11. Patient with atrial fibrillation discharged on oral anticoagulants unless contraindicated‡
12. Patient discharged on an antihypertensive agent unless contraindicated‡
13. Patient received risk factor modification advice before leaving the hospital unless patient had severe cognitive impairment or communication
impairment, or otherwise contraindicated‡
14. Ongoing care plan developed with and provided to the patient and/or family prior to discharge
▸ Clinical treatment process indicators (acute ST-segment elevation myocardial infarction)
1. ECG performed and interpreted before or within 10 min of arrival to the hospital for patient with chest pain or other acute coronary
syndrome symptoms
2. Patient received aspirin prior to arrival at the hospital
3. Patient received aspirin prior to being sent to the catheterisation laboratory
4. Eligible§ patient received fibrinolysis or percutaneous coronary intervention (PCI)¶
5. Eligible§ patient received fibrinolysis before or within 30 min of hospital arrival
6. Eligible§ patient, treated with PCI,¶ had a door-to-device time of 90 min or less for PCI-capable hospital, or 120 min or less if transferred
from a non PCI-capable hospital
7. Patient discharged with a written, individualised care plan (such as graded physical activity, smoking cessation therapies and addressing
psychosocial needs) unless discharged on palliative care pathway or where adherence to a secondary prevention plan is not indicated
8. Patient discharged on aspirin or dual antiplatelet therapy unless contraindicated‡
9. Patient discharged on a statin or lipid-lowering therapy unless contraindicated‡
10. Patient referred to cardiac rehabilitation or other secondary prevention programme unless contraindicated‡
11. Discharge summary provided to general practitioner or ongoing clinical provider of patient within 48 h of discharge
▸ Clinical treatment process indicators (hip fracture)
1. Patient initial pain score recorded within 30 min of arrival to the hospital
2. Patient received analgesia or nerve blocks within 30 min of arrival to the hospital, unless patient declined pain relief
3. Patient pain reassessed within 60 min of arrival to the hospital
4. Orthopaedic team notified within 60 min of patient arrival to the hospital
5. Surgery performed within 48 h of arrival to the hospital
6. Patient received prophylactic antibiotic treatment within 60 min prior to surgical incision
7. Patient received prophylactic thrombolytic treatment within 48 h of arrival to the hospital
8. Surgery performed with the aim of allowing patient to fully weight bear without restriction in the immediate postoperative period
9. Patient mobilisation started day after surgery unless contraindicated‡ or patient declined
10. Patient offered a dedicated mobilisation session to regain function at least once per day until discharge
11. Patient received a specialist falls assessment (including falls history, cause of fall index, and risk factors for falling and injury) from a
trained clinician prior to discharge
12. Patient received bone protection medication for secondary fracture prevention at discharge
*Eligibility for intravenous rt-PA: exclude patients who present at first emergency clinical contact more than 4.5 h after symptom onset,
patients with unknown time of onset or patients where thrombolysis is contraindicated.
†Intravenous rt-PA should only be given in hospitals with appropriately qualified clinicians and adequate infrastructure and facilities.48
Evidence of transfer policies and procedures will be sought in hospitals without the capability to perform intravenous rt-PA.
‡Contraindications include advanced care directives, being on a palliative care pathway and clinical judgement. Contraindication must be
documented.
§Eligibility for reperfusion: exclude patients who present at first emergency clinical contact more than 12 h after symptom onset, or where
reperfusion is contraindicated.
¶PCI should only be given in hospitals with appropriately qualified clinicians and adequate infrastructure and facilities.49 Evidence of transfer
policies and procedures will be sought in non PCI-capable hospitals.
Taylor N, et al. BMJ Open 2015;5:e010349. doi:10.1136/bmjopen-2015-010349 9
Open Access
Patient perceptions of care
Development and selection
A modiﬁed version of the eight-scale, self-report
UK-validated Patient Measure of Safety (PMOS) ques-
tionnaire,43 50 which assesses patients’ perceptions of the
factors contributing to patient safety, will measure sub-
jective patient factors. The instrument presents 43 items
on a 5-point Likert scale from 1 (strongly disagree) to 5
(strongly agree).
The PMOS has been piloted in one hospital (ethically
approved, HREC reference LNR/14/157) with stroke, AMI,
and hip fracture patients. Stage 1 involved four patients
who participated in a ‘think aloud’ study to provide an indi-
cation of the suitability of the content, length, and presenta-
tion of the measure. Stage 2 tested the reﬁned measure
with 31 patients to establish the suitability of the PMOS for
use with a cohort of patients similar to patients likely to par-
ticipate in DUQuA, and demonstrate the level of variability
produced by the measure.
Collection
Patients will complete the self-report paper question-
naire. Patients may request assistance to complete the
questionnaire from a family member or the trained clin-
ician responsible for administering the questionnaire.
Nationally recorded clinical outcomes
Development and selection
Clinical outcomes will be determined by analysing
routine data collected by hospitals and submitted to the
Australian Institute of Health and Welfare (AIHW), a
national Australian Government data collection agency.
Data will include the number of cases of each condition
discharged by diagnosis, (including stratiﬁcation by age
and gender), in-hospital mortality, length of hospital
stay, readmission, and mortality. Data will also be col-
lected for the number of: percutaneous coronary inter-
ventions (AMI), thrombolysis procedures (stroke), and
hip fracture operations performed in each hospital over
the study period.
Collection
The DUQuA team will retrieve the required data from
the AIHW.
Data analysis
The analysis plan for each research question is presented in
table 4. Descriptive statistics will summarise the spread, fre-
quencies or distributions of the variables of interest. Simple
correlations, linear and logistic regression and multilevel
modelling will be undertaken. The exact approach to the
statistical analysis will depend on the distribution of the
data, the variables that will need to be adjusted for (eg, case
mix), and the ﬁnal sample size achieved.
Multivariate modelling will take the form of a multi-
level or hierarchical model in the ﬁrst instance; with hos-
pitals at the top level.ii This type of regression will adjust
for both hospital-level and department-level covariates.
Subject to the results of this modelling, the levels may
be adjusted to select individual patient impact measures
as level 1 or, alternatively, a single-level model utilised.
Employing multilevel methods will allow for the amount
of variation in patient-level factors attributed to the hos-
pital and department level, as well as which factors con-
tribute to this variation, to be identiﬁed.
Ethics and dissemination
Regionally based Human Research Ethics Committees
(HRECs) in Australia have approved the DUQuA project
Table 4 DUQuA statistical analysis plan
Research question Statistical analysis Test
What department-level factors are
associated with patient-level factors?
Test the relationship between department-level factors
and patient-level factors, adjusting for higher level
hospital variation
Multilevel modelling
Test the relationship between the ED variables and
patient-level factors
Regression modelling
Test the relationship between patient perceptions,
clinical treatment processes and clinical outcomes
Correlations
Test the effect of transfers on patient-level factors Regression, correlation
What organisation level-factors are
associated with patient-level factors?
How much to organisation factors
contribute to the total variation?
Test the relationship between organisation-level QMS
and department-level QMS, leadership, and culture
Regression, correlation,
Test the relationship between organisation-level factors
and patient-level factors
Multilevel modelling,
regression
Identify the amount of variation in patient-level factors
attributable to organisation-level and department-level
variables
Multilevel modelling
DUQuA, Deepening our Understanding of Quality in Australia; ED, emergency department; QMS,quality management systems.
iiSample size was calculated based on a two level hierarchical model,
with hospital as the higher level. This model structure was selected as it
will likely be the model requiring the largest sample, and which
answers the primary research questions. Additional models that are
tested will give more precise estimates as their sample size
requirements will likely be less.
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for NSW (14/206)iii, VIC (15/36)iii, ACT (15/131)iii, SA
(15/260)iii, WA (15/118)iii and QLD (15/361)iii.
Remaining regionally based ethical applications are
under review, and governance requests for participating
hospitals will be submitted following conﬁrmation of the
ﬁnal sample.
Results of the DUQuA project will be disseminated to
participating hospitals in the form of conﬁdential
national and international benchmarking reports with a
set of data-driven recommendations. An extensive publi-
cation plan will support the dissemination of results
including reporting on the international validation of
measurement tools, associations between measures using
linear and multilevel models, the extent to which hos-
pital benchmarking can identify consistent high and low
performers, and the impact of the ED and patient trans-
fers on the delivery of care for the three selected condi-
tions. This ground-breaking study, with international
implications, has the potential to build a coalition of
hospitals for subsequent interventional work, inﬂuence
policymaker decisions on the implementation of quality
and safety systems and processes, and ultimately improve
the delivery of patient care in Australian hospitals.
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